Skip to main content

Table 2 Patient demographics and clinical characteristics

From: Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

 

Overall (N = 1030)

Stage IIIB (n = 119)

Stage IV

(n = 911)

Mean agea, years (SD)

64.5 (10.1)

62.4 (10.6)

64.8 (10.0)

Male sex, n (%)

679 (65.9)

86 (72.3)

593 (65.1)

Mean body mass indexb, kg/m2 (SD)

24.0 (3.4)

24.4 (3.7)

24.0 (3.3)

Current/former smokerc, n (%)

787 (77.9)

98 (83.8)

689 (77.2)

Histological tumour type, n (%)

 Non-squamous

724 (70.3)

73 (61.3)

651 (71.5)

 Squamous

306 (29.7)

46 (38.7)

260 (28.5)

Mean disease durationd, weeks (SD)

35.9 (45.0)

27.6 (40.1)

37.1 (45.5)

Receiving second- or later-line therapye, n (%)

302 (29.5)

21 (17.6)

281 (31.1)

ECOG PS, n (%)

 0

200 (19.4)

24 (20.2)

176 (19.3)

 1

448 (43.5)

53 (44.5)

395 (43.4)

 2

282 (27.4)

29 (24.4)

253 (27.8)

 3

82 (8.0)

13 (10.9)

69 (7.6)

 4

18 (1.7)

0 (0.0)

18 (2.0)

Comorbiditiesf, n (%)

 COPD

362 (35.3)

36 (30.5)

326 (35.9)

 Hypertension

335 (32.7)

25 (21.2)

310 (34.1)

 Anxiety

158 (15.4)

25 (21.2)

133 (14.6)

 Hyperlipidaemia

131 (12.8)

16 (13.6)

115 (12.7)

 Depression

112 (10.9)

15 (12.7)

97 (10.7)

 Diabetes mellitus

112 (10.9)

15 (12.7)

97 (10.7)

 Emphysema

107 (10.4)

8 (6.8)

99 (10.9)

 Ischaemic heart disease

90 (8.8)

7 (5.9)

83 (9.1)

 Bronchitis

87 (8.5)

8 (6.8)

79 (8.7)

 Peripheral vascular disease

67 (6.5)

4 (3.4)

63 (6.9)

 None

314 (30.6)

35 (29.7)

279 (30.7)

Current employment statusg, n (%)

 Retired

614 (60.4)

66 (55.9)

548 (61.0)

 Working (full-time)

149 (14.7)

28 (23.7)

121 (13.5)

 Working (part-time)

65 (6.4)

4 (3.4)

61 (6.8)

 Unemployed

105 (10.3)

11 (9.3)

94 (10.5)

 Otherh

83 (8.2)

9 (7.6)

74 (8.2)

  1. COPD chronic obstructive pulmonary disease; ECOG PS Eastern Cooperative Oncology Group Performance Status; NSCLC non-small cell lung cancer; SD standard deviation
  2. Patient numbers given at top of column apply in all cases unless noted below
  3. aPatients reported to be 90+ years of age were assumed to be 90 years of age for the purposes of this analysis; overall, N = 1028; stage IV, n = 909
  4. bOverall, N = 926; stage IIIB, n = 108; stage IV, n = 818
  5. cOverall, N = 1010; stage IIIB, n = 117; stage IV, n = 893
  6. dOverall, N = 1015; stage IV, n = 896
  7. eOverall, N = 1022; stage IV, n = 903
  8. fComorbidities shown are those occurring in more than 5% of patients in either NSCLC stage subgroup; overall, N = 1026; stage IIIB, n = 118; stage IV, n = 908
  9. gOverall, N = 1016; stage IIIB, n = 118; stage IV, n = 898
  10. hIncludes homemakers and students